Literature DB >> 26974299

Bacterial Respiratory Infections Complicating Human Immunodeficiency Virus.

Charles Feldman1, Ronald Anderson2.   

Abstract

Opportunistic bacterial and fungal infections of the lower respiratory tract, most commonly those caused by Streptococcus pneumoniae (the pneumococcus), Mycobacterium tuberculosis, and Pneumocystis jirovecii, remain the major causes of mortality in those infected with human immunodeficiency virus (HIV). Bacterial respiratory pathogens most prevalent in those infected with HIV, other than M. tuberculosis, represent the primary focus of the current review with particular emphasis on the pneumococcus, the leading cause of mortality due to HIV infection in the developed world. Additional themes include (1) risk factors; (2) the predisposing effects of HIV-mediated suppression on pulmonary host defenses, possibly intensified by smoking; (3) clinical and laboratory diagnosis, encompassing assessment of disease severity and outcome; and (4) antibiotic therapy. The final section addresses current recommendations with respect to pneumococcal immunization in the context of HIV infection, including an overview of the rationale underpinning the current "prime-boost" immunization strategy based on sequential administration of pneumococcal conjugate vaccine 13 and pneumococcal polysaccharide vaccine 23. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26974299     DOI: 10.1055/s-0036-1572558

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  2 in total

Review 1.  Epidemiology, virulence factors and management of the pneumococcus.

Authors:  Charles Feldman; Ronald Anderson
Journal:  F1000Res       Date:  2016-09-14

2.  Case fatality rate and viral aetiologies of acute respiratory tract infections in HIV positive and negative people in Africa: The VARIAFRICA-HIV systematic review and meta-analysis.

Authors:  Sebastien Kenmoe; Jean Joel Bigna; Abdou Fatawou Modiyingi; Marie S Ndangang; Paul Alain Ngoupo; Fredy Brice N Simo; Serges Tchatchouang; Elvis Temfack; Richard Njouom
Journal:  J Clin Virol       Date:  2019-06-28       Impact factor: 3.168

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.